期刊文献+

rhBNP对心肌梗死后心肌细胞病理学和细胞凋亡的研究 被引量:4

Effects of recombinant human brain natriuretic peptide on myocardial pathology and apoptosis after myocardial infarction in rats
下载PDF
导出
摘要 目的:观察rhBNP对大鼠心肌梗死后心肌细胞病理学和细胞凋亡的影响。方法:建立大鼠心肌梗死模型,分为MI对照组和BNP治疗组。治疗组给予rhBNP连续静滴4周,治疗48 h、1、2、3和4周时处死大鼠,进行心肌组织切片HE染色,TUNEL法测心肌细胞凋亡指数MAI,免疫组化测Fas与FasL蛋白阳性染色指数。结果:治疗组MAI和Fas/Fasl蛋白阳性率与对照组比较下降有显著性差异(P<0.05)。结论:连续给予rhBNP能够通过减少MI后心肌细胞凋亡保护缺血心肌,达到改善心功能的目的。 Objective:To assess the effect of long-term infusion of recombinant human brain natriuretic peptide(rhBNP) on myocardial pathology and apoptosis after myocardial infarction(MI) in rats.Methods: All rats were divided into rhBNP treatment group and MI control group.The MI rats in treatment group were treated by intravenous rhBNP injection(4 weeks).Myocardial tissues of rats were obtained after treatment of 48 hours,1,2,3 and 4 weeks.The tissue sections were stained with hematoxylin and eosin(HE).Myocardial apoptotic index(MAI) was determined by TUNEL and Fas/FasL protein was detected by immunohistochemical method.Results: Both MAI and Fas/FasL protein in treatment group were significantly reduced compared with control group(P0.05).Conclusion: Continuous rhBNP injection may effectively protect myocardial cells after myocardial infarction through reducing myocardial apoptosis,which could improve cardiac function.
机构地区 解放军
出处 《西北国防医学杂志》 CAS 2012年第2期125-127,共3页 Medical Journal of National Defending Forces in Northwest China
关键词 心肌梗死 重组人脑利钠肽 病理学 凋亡 大鼠 Myocardial infarction Recombinant human brain natriuretic peptide Pathology Apoptosis Rats
  • 相关文献

参考文献2

二级参考文献23

  • 1Cao L, Gardner DG. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension, 1995,25:227-234.
  • 2Abraham WT, Lowes BD, Ferguson DA, et al. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail, 1998,4:37-44.
  • 3Mills RM, LeJemtel TH, Horton DP, et al. Sustained hemodynamic effects of an infusion of nesiritide ( human B-type natriuretic peptide)in heart failure: a randomized, double-blind, placebo-controlled clinical trial Natrecor Study Group. J Am Coil Cardiol, 1999,34:155-162.
  • 4Silver MA, Horton DP, Ghali JK, et aL Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol, 2002,39 :798-803.
  • 5Colucci WS, Elkayam U, Horton DP, et al. Intravenous nesiritide,a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Meal, 2000,343:246-253.
  • 6Emerman CL Safety and efficacy of nesiritide for the treatment of decompensated heart failure. Bey Cardiovasc Med, 2002,3 Suppl 4 :S28 -S34.
  • 7Peacock WF, Emerman CE, Doleh M, et al. The incidence of non-ST segment elevation MI in emergency department patients presenting with decompensated heart failure. Congest Heart Fail, 2003,9:303-308.
  • 8Peacock WF 4th, Emerman CL, Young J. Nesiritide in congestive heart failure associated with acute coronary syndromes: a pilot study of safety and efficacy. J Card Fail, 2004,10 : 120-125.
  • 9Peacock WF, Emerman CL, Silver MA. Nesiritide added to standard care favorably reduces systolic blood pressure compared with standard care alone in patients with acute decompensated heart failure. Am J Emerg Med, 2005,23:327-331.
  • 10Zellner C, Protter AA, Ko E, et al. Coronary vasodilator effects of BNP: mechanisms of action in coronary conductance and resistance arteries. Am J Physiol, 1999, 276(3 Pt 2) :H1049-H1057.

共引文献119

同被引文献52

  • 1宋靖,弓慧杰,任凌.rhBNP对心衰家兔模型心脏保护机制的研究[J].黑龙江医学,2013,37(3):161-163. 被引量:1
  • 2Rademaker MT, Charles C J, Melton IC, et al. Monitoring of heart failure : comparison of left atrial pressure with intrathoracic imped- ance and natriuretic peptide measurements in an experimental model of ovine heart failure. Clin Sci (Lond) , 2011,120 ( 5 ) : 207- 217.
  • 3Toshihiko G, Nobuyuki O, Kazuaki W, et al. Usefulness of plasma brain natriuretic peptide measurement and tissue doppler imaging in identifying isolated left ventricular diastolic dysfunction without heart failure. Am J Cardiol,2010,106( 1 ) :87-91.
  • 4Dries DL. Natriuretic peptides and the genomics of left-ventricular hypertrophy. Heart Fail Clin,2010,6( 1 ) :55-64.
  • 5George I, Xydas S, Klotz S, et al. Long-term effects of B-type na- triuretic peptide infusion after acute myocardial infarction in a rat model. J Cardiovasc Pharmacol,2010,55 (1) :14-20.
  • 6O'Tiemey PF, Chattergoon NN, Louey S, et al. Atrial natriuretic peptide inhibits angiotensin Ⅱ-stimulated proliferation in fetal cardiomyocytes. J Physiol,2010,588( Pt 15 ) :2879-2889.
  • 7Yu JZ, Bondy GP, Allard MF, et al. Serum from patients with chronic renal insufficiency alters growth characteris- tics and ANP mRNA expression of adult rat cardiac rnyo- cytes[J]. J Mol Cell Cardiol,1996,28(12):2429-2441.
  • 8Schluter KD,Goldberg Y,Taimor G,et al. Role of phos phatidylinositol 3- kinase activation in the hypertrophic growth of adult ventricular cardiomyocytes[J]. Cardio vasc Res,1998,40(1) :174-181.
  • 9Clark WA,Decker ML, Behnke BM, et al. Cell contact as an independent factor modulating cardiac myocytes hy pertrophy and survival in longterm primary culture[J]. J Mol Cell Cardiot,1998,30(1): 139-155.
  • 10Delgado MA, Zamorano JL. Atorvastatin calcium plus amlodipine for the treatment of hypertension[J]. Expert Opin Pharmacother, 2012,13 (18): 2673 - 2685.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部